2H-Dibenzo[cd,g]indazol-6-one

ID: ALA1725279

Chembl Id: CHEMBL1725279

Max Phase: Preclinical

Molecular Formula: C14H8N2O

Molecular Weight: 220.23

Molecule Type: Small molecule

Names and Identifiers

Synonyms: SP-600125

Canonical SMILES:  Oc1c2ccccc2c2c3c(cccc13)N=N2

Standard InChI:  InChI=1S/C14H8N2O/c17-14-9-5-2-1-4-8(9)13-12-10(14)6-3-7-11(12)15-16-13/h1-7,17H

Standard InChI Key:  KRIUNPBAQZGFQA-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA1725279

   SP-600125

Molecule Features

Natural Product: Yes

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 220.23

Molecular Weight (Monoisotopic): 220.0637

AlogP: 4.43

#Rotatable Bonds: ┄

Polar Surface Area: 44.95

Molecular Species: NEUTRAL

HBA: 3

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 3

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 7.14

CX Basic pKa: ┄

CX LogP: 4.08

CX LogD: 3.64

Aromatic Rings: 3

Heavy Atoms: 17

QED Weighted: 0.44

Np Likeness Score: 0.27

References

1. Fabian MA, Biggs WH, Treiber DK, Atteridge CE, Azimioara MD, Benedetti MG, Carter TA, Ciceri P, Edeen PT, Floyd M, Ford JM, Galvin M, Gerlach JL, Grotzfeld RM, Herrgard S, Insko DE, Insko MA, Lai AG, Lélias JM, Mehta SA, Milanov ZV, Velasco AM, Wodicka LM, Patel HK, Zarrinkar PP, Lockhart DJ..  (2005)  A small molecule-kinase interaction map for clinical kinase inhibitors.,  23  (3): [PMID:15711537] [10.1038/nbt1068]

2. Ijjaali I, Petitet F, Dubus E, Barberan O, Michel A..  (2007)  Assessing potency of c-Jun N-terminal kinase 3 (JNK3) inhibitors using 2D molecular descriptors and binary QSAR methodology.,  15  (12): [PMID:17451961] [10.1016/j.bmc.2007.03.062]

3. Asano Y, Kitamura S, Ohra T, Aso K, Igata H, Tamura T, Kawamoto T, Tanaka T, Sogabe S, Matsumoto S, Yamaguchi M, Kimura H, Itoh F..  (2008)  Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1).,  16  (8): [PMID:18313304] [10.1016/j.bmc.2008.02.027]

4. Fedorov O, Marsden B, Pogacic V, Rellos P, Müller S, Bullock AN, Schwaller J, Sundström M, Knapp S..  (2007)  A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.,  104  (51): [PMID:18077363] [10.1073/pnas.0708800104]

5. Bruchas MR, Yang T, Schreiber S, Defino M, Kwan SC, Li S, Chavkin C..  (2007)  Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase.,  282  (41): [PMID:17702750] [10.1074/jbc.m705540200]

6. Chen X, Wilson LJ, Malaviya R, Argentieri RL, Yang SM..  (2008)  Virtual screening to successfully identify novel janus kinase 3 inhibitors: a sequential focused screening approach.,  51  (21): [PMID:18844338] [10.1021/jm800662z]

7. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, Cohen P..  (2007)  The selectivity of protein kinase inhibitors: a further update.,  408  (3): [PMID:17850214] [10.1042/bj20070797]

8. Siddiqui MA, Reddy PA..  (2010)  Small molecule JNK (c-Jun N-terminal kinase) inhibitors.,  53  (8): [PMID:20146479] [10.1021/jm9003279]

9. Yuan J, Johnson RL, Huang R, Wichterman J, Jiang H, Hayton K, Fidock DA, Wellems TE, Inglese J, Austin CP, Su XZ..  (2009)  Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.,  5  (10): [PMID:19734910] [10.1038/nchembio.215]

10. Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, Dirks PB..  (2007)  Chemical genetics reveals a complex functional ground state of neural stem cells.,  3  (5): [PMID:17417631] [10.1038/nchembio873]

11. PubChem BioAssay data set, 

12. PubChem BioAssay data set, 

13. PubChem BioAssay data set, 

14. PubChem BioAssay data set, 

15. PubChem BioAssay data set, 

16. PubChem BioAssay data set, 

17. PubChem BioAssay data set, 

18. Hamada N, Tanaka A, Fujita Y, Itoh T, Ono Y, Kitagawa Y, Tomimori N, Kiso Y, Akao Y, Nozawa Y, Ito M..  (2011)  Involvement of heme oxygenase-1 induction via Nrf2/ARE activation in protection against H2O2-induced PC12 cell death by a metabolite of sesamin contained in sesame seeds.,  19  (6): [PMID:21345685] [10.1016/j.bmc.2011.01.059]

19. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A..  (2010)  Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.,  23  (1): [PMID:20014752] [10.1021/tx900326k]

20. PubChem BioAssay data set, 

21. Okamoto M, Kojima H, Saito N, Okabe T, Masuda Y, Furuya T, Nagano T..  (2011)  Virtual screening and further development of novel ALK inhibitors.,  19  (10): [PMID:21515061] [10.1016/j.bmc.2011.04.008]

22. Bryk R, Wu K, Raimundo BC, Boardman PE, Chao P, Conn GL, Anderson E, Cole JL, Duffy NP, Nathan C, Griffin JH..  (2011)  Identification of new inhibitors of protein kinase R guided by statistical modeling.,  21  (13): [PMID:21632247] [10.1016/j.bmcl.2011.04.149]

23. Stebbins JL, De SK, Pavlickova P, Chen V, Machleidt T, Chen LH, Kuntzen C, Kitada S, Karin M, Pellecchia M..  (2011)  Design and characterization of a potent and selective dual ATP- and substrate-competitive subnanomolar bidentate c-Jun N-terminal kinase (JNK) inhibitor.,  54  (18): [PMID:21815634] [10.1021/jm200479c]

24. PubChem BioAssay data set, 

25. PubChem BioAssay data set, 

26. Kato E, Sasaki Y, Takahashi N..  (2011)  Sodium dl-α-tocopheryl-6-O-phosphate inhibits PGE₂ production in keratinocytes induced by UVB, IL-1β and peroxidants.,  19  (21): [PMID:21945458] [10.1016/j.bmc.2011.08.067]

27. PubChem BioAssay data set, 

28. PubChem BioAssay data set, 

29. Morikawa T, Sueyoshi M, Chaipech S, Matsuda H, Nomura Y, Yabe M, Matsumoto T, Ninomiya K, Yoshikawa M, Pongpiriyadacha Y, Hayakawa T, Muraoka O..  (2012)  Suppressive effects of coumarins from Mammea siamensis on inducible nitric oxide synthase expression in RAW264.7 cells.,  20  (16): [PMID:22831798] [10.1016/j.bmc.2012.06.031]

30. Gao Y, Davies SP, Augustin M, Woodward A, Patel UA, Kovelman R, Harvey KJ..  (2013)  A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,  451  (2): [PMID:23398362] [10.1042/bj20121418]

31. PubChem BioAssay data set, 

32. PubChem BioAssay data set, 

33. PubChem BioAssay data set, 

34. Kim MH, Lee J, Jung K, Kim M, Park YJ, Ahn H, Kwon YH, Hah JM..  (2013)  Syntheses and biological evaluation of 1-heteroaryl-2-aryl-1H-benzimidazole derivatives as c-Jun N-terminal kinase inhibitors with neuroprotective effects.,  21  (8): [PMID:23498914] [10.1016/j.bmc.2013.02.021]

35. Kusakabe K, Ide N, Daigo Y, Tachibana Y, Itoh T, Yamamoto T, Hashizume H, Hato Y, Higashino K, Okano Y, Sato Y, Inoue M, Iguchi M, Kanazawa T, Ishioka Y, Dohi K, Kido Y, Sakamoto S, Yasuo K, Maeda M, Higaki M, Ueda K, Yoshizawa H, Baba Y, Shiota T, Murai H, Nakamura Y..  (2013)  Indazole-based potent and cell-active Mps1 kinase inhibitors: rational design from pan-kinase inhibitor anthrapyrazolone (SP600125).,  56  (11): [PMID:23634759] [10.1021/jm4000215]

36. Zhong C, Liu XH, Chang J, Yu JM, Sun X..  (2013)  Inhibitory effect of resveratrol dimerized derivatives on nitric oxide production in lipopolysaccharide-induced RAW 264.7 cells.,  23  (15): [PMID:23791078] [10.1016/j.bmcl.2013.05.058]

37. Laufer R, Ng G, Liu Y, Patel NK, Edwards LG, Lang Y, Li SW, Feher M, Awrey DE, Leung G, Beletskaya I, Plotnikova O, Mason JM, Hodgson R, Wei X, Mao G, Luo X, Huang P, Green E, Kiarash R, Lin DC, Harris-Brandts M, Ban F, Nadeem V, Mak TW, Pan GJ, Qiu W, Chirgadze NY, Pauls HW..  (2014)  Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides.,  22  (17): [PMID:25043312] [10.1016/j.bmc.2014.06.027]

38. Huh JE, Lee WI, Kang JW, Nam D, Choi DY, Park DS, Lee SH, Lee JD..  (2014)  Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.,  77  (11): [PMID:25397676] [10.1021/np500417d]

39. Koch P, Gehringer M, Laufer SA..  (2015)  Inhibitors of c-Jun N-terminal kinases: an update.,  58  (1): [PMID:25415535] [10.1021/jm501212r]

Source

Source(2):

• Scientific Literature
• PubChem BioAssays